US-based specialty drugs company Supernus Pharmaceuticals has sued generics maker Actavis, accusing it of infringing three patents related to an antiepileptic drug.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Supernus, Actavis, patent infringement, ANDA